Explore Our Clinical Resources

MRIoA offers an extensive library of educational resources that help our clients stay abreast of emerging clinical procedures and therapies to support improved clinical decision making.

Sign up to receive email notifications of our clinical resources and upcoming webinars: Click here for more information.

At A Glance


  • Empowering Better Healthcare Choices: An animated video to illustrate how MRIoA is helping to transform the patient/member experience with 2nd opinions and virtual access to prominent MD specialists.
  • MyCareChoices (Virtual 2nd Opinion): An animated video to illustrate MyCareChoices workflow process to provide patient/members with 2nd opinions and virtual access to prominent MD specialists.


  • MRIoA Behavioral Health COVID-19 Solution: Due to COVID-19, behavioral health challenges are being exacerbated.  MRIoA developed solutions at the request of our clients to meet the higher demand.
  • MRIoA New Clinical Bench Strength Infographic: MRIoA offers the largest, most extensive review network in the industry. We have over 30 internal medical directors, 26 nurses and 500+ physicians across 150+ specialties with licensure in all 50 states.

White Papers

Case Studies


  • Mark your calendars for October 21, 2020 at 1:00 pm ET to join us for discussion on pressing Pharmacy issues that include Opioid, Orphan Drugs and Specialty Drugs. Join Byron Harris, PharmD, BCPS, Sr. Director, Clinical Services and other key industry leaders for this important discussion.
  • “Empowering Better Healthcare Choices” Webinar: Hear how Medical Review Institute of America (MRIoA) is transforming the member experience with simplified virtual access for patients that enables the best treatment options from prominent MD specialists. We help healthcare stakeholders move to a new level in the care process with MyCareChoices™ + Prior Authorizations, Specialty Products, Prior Authorizations and Appeals.

Gain Control of Your Specialty and Orphan Drug Spend Starting Today

Please join industry leaders for an informative discussion on gaining control over high cost specialty and orphan drug costs.

Join us on October 21, 2020
30 minutes discussion and 15 minutes Q&A

1:00 pm ET | 12:00 pm CT | 11:00  am MT | 10:00 am PT

Reserve Your Seat Today